Lung Cancer Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
Pemed - Model S - Injection
Used to treat pleural mesothelioma and non-small-cell lung ...
CONTACT SUPPLIER -
Software vendorbased in Paris, FRANCE
SIVAN is an e-health company committed to improve the lives of cancer patients worldwide. SIVAN developed Moovcare, the first application that was clinically validated and proven to extend the life of lung cancer patients. Moovcare helps physicians ...
Moovcare - Digital Therapeutic Tools
Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients. A Class I medical device, Moovcare has been proven in ...
CONTACT SUPPLIER -
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Model 820TCR - Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1)
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. T-Cure estimates ...
CONTACT SUPPLIER -
Software vendorbased in Cambridge, MASSACHUSETTS (USA)
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services ...
Aiforia - Version PD-L1 - Clinical AI Model for Lung Cancer
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. ...
CONTACT SUPPLIER -
Manufacturerbased in Moscow, RUSSIA
The Russian company Intellogic LLC specializes in creating healthcare products using artificial intelligence technologies. Healthcare costs in all over the world are growing faster than income of people. We develop modern products that will increase ...
Intellogic - Chest CT Studies Revision Technology for Lung Cancer Detection
. Meanwhile chest CT scan makes it possible to detect a significantly larger number of diseases, especiallylung ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Nucleix EpiCheck - Early Stage Lung Cancer Detection Unit
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, ...
CONTACT SUPPLIER -
Service providerbased in Nottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Early Detection of Lung Cancer
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most ...
CONTACT SUPPLIER -
Manufacturerbased in Carlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
Model VAC2 - Immuno-Oncology for Non-Small Cell Lung Cancer (NSCLC)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. ...
CONTACT SUPPLIER -
Manufacturerbased in Xiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
AmoyDx - Pan Lung Cancer PCR Panel
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver ...
CONTACT SUPPLIER -
Manufacturerbased in Durham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
GeneCentric - Lung Cancer Profilers (LSP)
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
CONTACT SUPPLIER -
Manufacturerbased in Providence, RHODE ISLAND (USA)
Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines. We're working to bring together the interdisciplinary ...
Therapeutic Antibodies for Effective Treatment of Non-Small Cell Lung Cancer
, the tumor suppressor PTEN, and p53. In addition, OCX-253 is a master stimulator of immune checkpoint inhibitor pathways. and plays a critical role in the pathogenesis of primary and metastatic lung cancer. Other ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey. We ask the right questions and provide answers that give physicians and patients a clearer ...
Percepta - Lung Cancer Diagnostics
Avoiding unnecessary procedures, speeding time to diagnosis and appropriate treatment. Lung cancer is the leading cancer killer worldwide, causing approximately 1.8 million deaths each year. ...
CONTACT SUPPLIER -
Manufacturerbased in Valladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
DiagnoLung - Non-Invasive Early Detection Test Cutting Edge Liquid Biopsy Technology for Lung Cancer
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with ...
CONTACT SUPPLIER -
Manufacturerbased in Rockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
PAULAs - Blood Test - Early Detection of Lung Cancer
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed ...
CONTACT SUPPLIER -
Manufacturerbased in Edgewater, NEW JERSEY (USA)
Menssana Research is the leading developer of advanced new breath tests for detection of disease. Early detection of diseases can often bring huge benefits: some cancers can be completely eradicated if they are detected early and treated promptly. ...
Menssana - Breath Test for Lung Cancer
Every year in the U.S.A., 99,000 men and 78,000 women develop lung cancer, and only 14% of them are still alive five years later. Fortunately, early detection and treatment can reduce the number of deaths. Clinical ...
CONTACT SUPPLIER -
Manufacturerbased in Meyzieu, FRANCE
CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in ...
CTIBiotech - Primary Lung Cancer
Although much is known about the appearance, growth and spread of cancer in the human body, effective and rapid treatments for many cancer types are yet to be found. Chemo- and radio- therapies have made much ...
CONTACT SUPPLIER -
Manufacturerbased in Shanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius HANBEITAI - Bevacizumab Injection
HANBEITAI (bevacizumab injection) was approved by the NMPA in November 2021. It is indicated for metastatic colorectal cancer (mCRC), advanced, metastatic or recurrent non-small cell lung cancer ...
CONTACT SUPPLIER -
Technologybased in Phoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Model LuCED Test - Lung Cell Evaluation Device
The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by detecting the abnormal cells. ...
CONTACT SUPPLIER -
Manufacturerbased in Louisville, KENTUCKY (USA)
Breath Diagnostics, Inc. (“Breath-Dx” or “the Company”), is a medical-device diagnostics company developing a novel, patented breath analysis system to quantify cancer specific markers in exhaled breath. The Company’s proprietary technology, ...
OneBreath Technology
method for lung cancer detection/diagnosis to date. The OneBreath™ test can be done in office-based, and retail (pharmacy/drugstores) settings, enabling greater accessibility to lung ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
Eutilex - Model EU307(GPC3-IL18) - Hepatocellular Carcinoma and Non-Small Cell Lung Cancer
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you